Commentary: Public Outreach by the FDA: Evaluating Oversight of Human Drugs and Medical Devices

Journal of Law, Medicine and Ethics 37 (4):625-628 (2009)
  Copy   BIBTEX


As nanotechnology emerges as an important public policy issue, the FDA's relationship with society is about to be tested. Most would agree that fostering public input will be critical to developing effective public policy for nanotechnology. Yet, it will not be easy. Low public confidence in the FDA, the general lack of knowledge about nanotechnology among ordinary Americans, and the way in which the “average” citizen obtains and evaluates knowledge about a public policy issue all pose serious challenges to any public outreach by the FDA. It will be necessary for the FDA to be attentive to not only its own public messages, but also to who is listening and how those messages are being perceived



    Upload a copy of this work     Papers currently archived: 91,122

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Commentary: Evaluating Oversight of Human Drugs and Medical Devices.Susan Bartlett Foote - 2009 - Journal of Law, Medicine and Ethics 37 (4):629-632.
Scientific self-regulation—so good, how can it fail?Patrick L. Taylor - 2009 - Science and Engineering Ethics 15 (3):395-406.
Revolution or Reform in Human Subjects Research Oversight.Steven Joffe - 2012 - Journal of Law, Medicine and Ethics 40 (4):922-929.


Added to PP

18 (#747,034)

6 months
2 (#889,309)

Historical graph of downloads
How can I increase my downloads?